09/30/2010
Federal Register Notice: FDA’s proposed collection of information, “Petition to Request an Exemption From 100 Percent ...09/16/2010
Federal Register Notice: FDA’s Peripheral and Central Nervous System Drugs Advisory Committee and the Drug Safety and Risk M...09/16/2010
Federal Register Notice: FDA’s Tobacco Products Scientific Advisory Committee will meet 10/7, from 8 a.m. until 5 p.m. and 1...09/09/2010
Federal Register Notice: FDA has determined the regulatory review period for SyntheMed, Inc.’s Repel-CV is 4,023 days for ex...09/09/2010
Federal Register Notice: FDA has determined the regulatory review period for Chiel Jedang Corp. and Walter Reed Army Institute of ...09/09/2010
Federal Register Notice: FDA is making available a draft guidance for industry, Suicidality: Prospective Assessment of Occurrence ...09/08/2010
Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a Novartis Animal Health supplemen...09/08/2010
Federal Register Notice: FDA is making available a guidance, Class II Special Controls Guidance Document for Certain Percutaneous ...